Charles J. Casamento - Jan 3, 2025 Form 4 Insider Report for Eton Pharmaceuticals, Inc. (ETON)

Role
Director
Signature
/s/ James R. Gruber
Stock symbol
ETON
Transactions as of
Jan 3, 2025
Transactions value $
$0
Form type
4
Date filed
1/6/2025, 04:21 PM
Previous filing
Oct 23, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETON Employee Stock Option (Right to Buy) Award $0 +25K $0.00 25K Jan 3, 2025 Common Stock 25K $13.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest equally on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on January 3, 2026.

Remarks:

The reporting person has authorized and designated the named person to file this Form 4 on the reporting person's behalf for indefinite duration.